Literature DB >> 28382527

Multiple thrombophilia mutations as a possible cause of premature myocardial infarction.

Gabriela Dostálová1, Jan Bělohlávek2, Zuzana Hlubocká2, Kristýna Bayerová2, Petra Bobčiková3, Tomáš Kvasnička3, Jan Kvasnička3, Aleš Linhart2, Debora Karetová2.   

Abstract

The incidence of acute myocardial infarction (AMI) increases with clustering of predisposing risk factors. In younger subjects with a positive family history of AMI occurring in relatives under the age of 60 years without obvious risk factors for atherosclerosis, there is a potential for strong inherited traits contributing to the risk of coronary disease. Among them there is increasing evidence that hereditary thrombophilia may play a major role. We present a unique case of a patient developing AMI at the age of 48 years. In this patient, without traditional risk factors for atherosclerosis, eight mutations and polymorphisms in six different genes were identified: polymorphism of factor V Leiden (1691 GA), factor II prothrombin (20210 GA), methylenetetrahydrofolate reductase (MTHFR, 677 CT and 1298 AC), plasminogen activator inhibitor 1 (PAI-1) polymorphism 4G/5G and glycoprotein VI (GP6, 13254 TC, Ser219Pro). All could be involved in the pathogenesis of the arterial thrombosis. Although such associations are extremely rare, it underlines the importance of thrombophilia assessment in cases with otherwise unexpected coronary disease occurring at young age. According to our experience, in the case of documented hereditary thrombophilia lineal relatives should be examined and/or followed up.

Entities:  

Keywords:  Atherosclerosis; Myocardial infarction; Polymorphism; Thrombophilia

Mesh:

Substances:

Year:  2017        PMID: 28382527     DOI: 10.1007/s00508-017-1193-z

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  23 in total

1.  A case report of myocardial infarction in young patient with a parental history of premature cardiovascular death: combination of prothrombotic gene mutations.

Authors:  Nicoletta Botto; Massimiliano Mariani; Samantha Manfredi; Maria Grazia Andreassi
Journal:  Int J Cardiol       Date:  2007-10-24       Impact factor: 4.164

Review 2.  Nouvelle cuisine: platelets served with inflammation.

Authors:  Rick Kapur; Anne Zufferey; Eric Boilard; John W Semple
Journal:  J Immunol       Date:  2015-06-15       Impact factor: 5.422

3.  Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.

Authors:  Thomas Mueller; Renate Marschon; Benjamin Dieplinger; Dieter Haidinger; Alfons Gegenhuber; Werner Poelz; Gerald Webersinke; Meinhard Haltmayer
Journal:  J Vasc Surg       Date:  2005-05       Impact factor: 4.268

Review 4.  Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature.

Authors:  Jasna Lenicek Krleza; Gordana Jakovljevic; Ana Bronic; Désirée Coen Herak; Aleksandra Bonevski; Jasminka Stepan-Giljevic; Goran Roic
Journal:  Pathophysiol Haemost Thromb       Date:  2010-07-20

5.  Five prothrombotic polymorphisms and the prevalence of premature myocardial infarction.

Authors:  Vanessa Roldán; Rocío González-Conejero; Francisco Marín; Javier Pineda; Vicente Vicente; Javier Corral
Journal:  Haematologica       Date:  2005-03       Impact factor: 9.941

Review 6.  Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.

Authors:  Robert J Kim; Richard C Becker
Journal:  Am Heart J       Date:  2003-12       Impact factor: 4.749

7.  The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.

Authors:  Füsun Ozmen; M Mahir Ozmen; Nejdet Ozalp; Nejat Akar
Journal:  Ulus Travma Acil Cerrahi Derg       Date:  2009-03

8.  Massive pulmonary embolism associated with Factor V Leiden, prothrombin, and methylenetetrahydrofolate reductase gene mutations in a young patient on oral contraceptive pills: a case report.

Authors:  Khalil M Charafeddine; Rami A Mahfouz; Georges Y Ibrahim; Ali T Taher; Jamal J Hoballah; Assad M Taha
Journal:  Clin Appl Thromb Hemost       Date:  2009-06-10       Impact factor: 2.389

9.  Influence of 9p21.3 genetic variants on clinical and angiographic outcomes in early-onset myocardial infarction.

Authors:  Diego Ardissino; Carlo Berzuini; Piera Angelica Merlini; Pier Mannuccio Mannucci; Aarti Surti; Noel Burtt; Benjamin Voight; Marco Tubaro; Flora Peyvandi; Marta Spreafico; Patrizia Celli; Daniela Lina; Maria Francesca Notarangelo; Maurizio Ferrario; Raffaela Fetiveau; Giorgio Casari; Michele Galli; Flavio Ribichini; Marco L Rossi; Francesco Bernardi; Nicola Marziliano; Pietro Zonzin; Francesco Mauri; Alberto Piazza; Luisa Foco; Luisa Bernardinelli; David Altshuler; Sekar Kathiresan
Journal:  J Am Coll Cardiol       Date:  2011-07-19       Impact factor: 24.094

10.  Causal relationship of susceptibility genes to ischemic stroke: comparison to ischemic heart disease and biochemical determinants.

Authors:  Paul Bentley; George Peck; Liam Smeeth; John Whittaker; Pankaj Sharma
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.